Renal Parenchymal Disease Treatment Options & Management

Renal parenchymal disease refers to damage to the functional tissue of the kidney (nephrons, interstitium, vasculature). Management targets the underlying etiology and slowing progression.

Common Etiologies & Directed Therapies

  • Hypertensive nephrosclerosis: Strict BP control (ACEi/ARB first-line).
  • Diabetic nephropathy: Glycemic control, ACEi/ARB, SGLT2 inhibitors.
  • Glomerulonephritis: Immunosuppression per histology (e.g., steroids, cyclophosphamide).
  • Obstructive uropathy: Relief of obstruction (stent, nephrostomy).
  • Chronic infection/reflux: Antibiotics, surgical correction.

General Supportive Measures

  • Blood pressure: Target <130/80 mmHg (KDIGO). ACEi/ARB reduce proteinuria.
  • Glycemic control: HbA1c ~7% individualized.
  • Lipid management: Statin for CVD risk reduction.
  • Diet: Low sodium (<2g/day), moderate protein (0.8g/kg), high fruits/vegetables; restrict K⁺/P if advanced CKD.
  • Lifestyle: Weight loss, exercise, smoking cessation, avoid NSAIDs.
  • Anemia/CKD-MBD: ESA, iron, phosphate binders, vitamin D analogs per guidelines.

Advanced Disease

When eGFR <15–20 mL/min: prepare for renal replacement therapy (dialysis, transplant) or conservative management.

Multidisciplinary care (nephrologist, dietitian, pharmacist) optimizes outcomes.

Kidney Disease - Related Articles